Specification for Rapidly Manufactured CPAP System to be used during the coronavirus (COVID-19) outbreak

This guidance is for devices which are most likely to confer therapeutic benefit on a patient requiring CPAP because of respiratory failure caused by the virus, used in the initial care of patients requiring urgent support.


Medicines and Healthcare products Regulatory Agency